Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
477.00    4.00 (0.85%)
Bid:
476.00
Ask:
477.00
Spread: 1.00 (0.21%)
Market Cap: £787.12m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Share Issue and Treasury

9 Dec 2013 07:00

RNS Number : 9688U
Oakley Capital Investments Limited
09 December 2013
 



09 December 2013

 

 

 

Oakley Capital Investments Limited

 

 

Share Issue and Treasury

 

 

On 4 November 2013 Oakley Capital Investments Limited ("the Company") announced that on 7 November 2013 it had sold 584,000 ordinary shares at £1.72 per share for settlement from treasury to institutional investors. It also announced on the same date that following this transaction the Company would hold 4,425,950 shares in treasury.

 

The Board has discovered that prior to the above transaction, 5,009,950 ordinary shares in OCL previously purchased by the Company were actually cancelled by the Company's registrar and not held in treasury.

 

In order to satisfy its obligations under the above ordinary share sale, OCL has issued 584,000 ordinary shares to its counterparty.

 

Further, in order to restore the Company's treasury stock to the previously disclosed level, OCL will issue 4,425,950 ordinary shares to Liberum Capital at the prevailing market price and repurchase immediately at the same price.

 

Application for admission to AIM has been made in respect of both tranches being 5,009,950 ordinary shares, and admission and trading is expected to occur on or around 13 December 2013.

 

Following this transaction the Company will hold 4,425,950 shares in treasury, therefore the number of ordinary shares in issue less the total number of treasury shares will be 123,699,050 and the total number of voting rights in the Company is 123,699,050.

 

 

For further information please contact:

 

Oakley Capital Investments Limited

+44 20 7766 6900

Peter Dubens, Director

FTI Consulting

+44 20 7831 3113

Edward Bridges / Emily Hartman

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Steve Pearce / Tom Fyson

 

 

 

About Oakley Capital Investments Limited

 

Oakley Capital Investments Limited is a Bermudan based company listed on AIM. OCIL seeks to provide investors with long term capital appreciation through its investment in Oakley Capital Private Equity L.P. and, over time, through co-investment opportunities.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSFSAFMMFDSELE
Date   Source Headline
9th Mar 20212:05 pmEQSHardman & Co Research : Hardman Talks | Oakley Capital Investments Management Discussion
1st Mar 20217:00 amRNSRefinancing of Career Partner Group
23rd Feb 20217:00 amRNSNotice of Results and Investor Presentation
19th Feb 20217:00 amRNSInvestment in Dexters
10th Feb 20217:00 amRNSDirector Dealing
29th Jan 20214:42 pmRNSDirector Dealing
27th Jan 20215:06 pmRNSDirector Dealing
27th Jan 20217:00 amRNSTrading update for the year ended 31 December 2020
26th Jan 20217:00 amRNSInvestment in idealista
7th Jan 20217:00 amRNSSale of the DWS division of the Daisy Group
22nd Dec 20204:11 pmRNSHolding(s) in Company
11th Dec 20202:33 pmRNSDirector Declaration
4th Dec 20203:58 pmRNSHolding(s) in Company
3rd Dec 20204:50 pmEQSHardman & Co Research: Oakley Capital Investments (OCI): NAV: conservative, robust and with growth upside
3rd Dec 20201:52 pmRNSTransaction in Own Shares
25th Nov 20207:00 amRNSHolding(s) in Company
23rd Oct 20207:00 amRNSDirector/PDMR Shareholding
22nd Oct 20207:00 amRNSAcquisition of WindStar Medical
6th Oct 202012:42 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSTransaction in Own Shares (Amendment)
2nd Oct 20204:33 pmRNSTransaction in Own Shares
2nd Oct 20207:00 amRNSShare Buy-Back Programme
1st Oct 20207:00 amRNSAcquisition of 7NXT
30th Sep 20201:54 pmRNSAppointment of Non-Executive Director
17th Sep 20207:00 amRNSOakley sells Casa.it to EQT
10th Sep 20207:00 amRNSResults for the six months ended 30 June 2020
1st Sep 20207:20 amEQSHardman & Co Research: Oakley Capital Investments (OCI) - initiation of coverage: 'When it rains gold, put out the bucket'
4th Aug 20203:09 pmRNSHolding(s) in Company
29th Jul 20206:15 pmRNSTransaction in Own Shares
29th Jul 20207:00 amRNSTrading update for the six months ended 30 June 20
15th Jul 20209:30 amRNSKepler Trust Intelligence: New Research
6th Jul 20207:00 amRNSCapital Commitment
30th Jun 20207:00 amRNSDirectorate Change
24th Jun 20206:02 pmRNSDirector Dealing
22nd Jun 202012:22 pmRNSHolding(s) in Company
19th Jun 20205:38 pmRNSDirector Dealing
19th Jun 20207:01 amRNSDirector Dealing
19th Jun 20207:00 amRNSDirector Dealing
18th Jun 20205:57 pmRNSHolding(s) in Company
18th Jun 20204:42 pmRNSTransaction in Own Shares
18th Jun 20207:00 amRNSShare Buy-Back
1st Jun 20202:25 pmRNSDirector Declaration
27th May 20205:01 pmRNSHolding(s) in Company
27th May 20207:00 amRNSResult of Annual General Meeting
22nd May 20204:33 pmRNSTime Out equity fundraise and OCI loan repayment
19th May 20207:00 amRNSDirector Declaration
7th May 20207:00 amRNSDirectorate Change and Total Voting Rights
1st May 20207:00 amRNSNotice of Annual General Meeting
8th Apr 20207:00 amRNSOakley completes sale of investment in Inspired
25th Mar 20207:00 amRNSCOVID-19 Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.